| 000 | 01388cam a2200193 4500500 | ||
|---|---|---|---|
| 005 | 20250112040111.0 | ||
| 041 | _afre | ||
| 042 | _adc | ||
| 100 | 1 | 0 |
_aRatone, Jean-Philippe _eauthor |
| 700 | 1 | 0 |
_a Poizat, Flora _eauthor |
| 700 | 1 | 0 |
_a Caillol, Fabrice _eauthor |
| 700 | 1 | 0 |
_a Giovannini, Marc _eauthor |
| 245 | 0 | 0 | _aPlace and evolution of endoscopic ultrasound-guided sampling for diagnosis in 2022 |
| 260 | _c2022. | ||
| 500 | _a92 | ||
| 520 | _aIn 2022, endoscopic ultrasound (EUS)-guided sampling with linear EUS scope is one of the main methods used for making diagnoses in this field. EUS-guided sampling is the cornerstone of the management of pancreatic solid mass but also other peridigestive lesions (cystic lesions, GISTs, etc.). EUS fine-needle aspiration (EUS-FNA), safe and efficient with a sensibility of over 85% and a specificity of over 95%, is being gradually replaced by EUS fine-needle biopsy (EUS-FNB), which enables better histological material acquisition without increasing morbidity. These evolutions, perfectly adapted to modern medicine (personalized with theranostic markers) have changed EUS usage, in particular cytopathology management. | ||
| 786 | 0 | _nHépato-Gastro & Oncologie Digestive | 29 | 6 | 2022-06-01 | p. 682-690 | 2115-3310 | |
| 856 | 4 | 1 | _uhttps://shs.cairn.info/journal-hepato-gastro-oncologie-digestive-2022-6-page-682?lang=en |
| 999 |
_c175175 _d175175 |
||